I think that was the New Jersey facility. The Spokane facility still has a few bugs to work out, and aparently the FDA won't rule until these things are done. Carter didn't sound like it was a big deal. Of course to us it is because we are sitting here waiting, and waitng, and waiting.
Market Data 
Markets 
AI
